Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade

NCT04435288 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Spondyloarthritis

Interventions

DRUG: week 24
DRUG: week 36
DRUG: Week 48
DRUG: Week 60

Sponsor

University Hospital, Ghent

Collaborators

[object Object]